Clinical Trials Sponsored by The Griffin Institute

Total 5036 results

Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Total Laryngectomy

Netherlands
Hellenic Institute for the Study of Sepsis

Completed

suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) (SAVE)

Virus Diseases | COVID-19 | Corona Virus Infection | Lower Respiratory Tract Infection Viral

Greece
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients (OpACIN)

Stage III Skin Melanoma

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Completed

Carboplatin-cyclophosphamide Combined With Atezolizumab (PROLOG)

Breast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial Cancer

Netherlands
Hellenic Institute for the Study of Sepsis

Completed

Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early (ACHIEVE)

Virus Diseases | COVID-19 | Corona Virus Infection

Greece
Hellenic Institute for the Study of Sepsis

Unknown

suPAR to Guide Antibiotics in Emergency Department

Sepsis

Greece
Hellenic Institute for the Study of Sepsis

Completed

Pulse Photoplethysmography as an Early Tool for the Diagnosis of Sepsis (PROUD-1)

Sepsis

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (PROVIDE)

Sepsis | Macrophage Activation Syndrome

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis (PROGRESS)

Sepsis

Greece
S.M.Chang, MD
The Methodist Hospital Research Institute

Completed

Reducing Radioisotope Dose: the Half-Dose CZT Study

Coronary Artery Disease

United States
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms

Breast Cancer Survivors | Climacteric Symptoms

Netherlands
Mayo Clinic
The Gertner Institute; ReAbility Online

Completed

Evaluation of a Tele-Rehabilitation Service Program

Stroke | Paresis

United States
The Cleveland Clinic
National Eye Institute (NEI)

Completed

PIONEER: Intraoperative and Perioperative OCT Study (PIONEER)

Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
The Netherlands Cancer Institute
Astellas Pharma Inc

Completed

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation (DARANA)

Prostate Cancer | Androgen Receptor Abnormal | DNA
The Netherlands Cancer Institute
Bristol-Myers Squibb

Completed

Nivolumab in Patients With Recurrent Malignant Mesothelioma (NivoMes)

Malignant Pleural Mesothelioma
The Advanced Gynecologic Surgery Institute
Medtronic - MITG

Withdrawn

a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. (VLocmyo)

Infertility | Uterine Fibroids

United States
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
The Methodist Hospital Research Institute
Schering-Plough

Terminated

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Carcinoma, Renal Cell

United States
The Methodist Hospital Research Institute
Oxford BioMedica

Completed

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Prostatic Neoplasms

United States
Rothman Institute Orthopaedics
The Anderson Orthopaedic Clinic

Completed

A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach

Osteoarthritis of the Hip

United States
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
The Cleveland Clinic

Completed

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
The Cleveland Clinic

Withdrawn

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Long Term Use of the Provox Vega 22.5

Total Laryngectomy

Netherlands
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (N08HME)

Total Laryngectomy

Netherlands
Vardalinstitutet The Swedish Institute for Health...

Unknown

Supported Employment in a Swedish Context

Psychosis

Sweden
The George Institute
ANZICS Clinical Trials Group

Completed

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Acute Renal Failure

Australia
Quadram Institute Bioscience
The Coca-Cola Company

Completed

Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink

Iron Deficiency

United Kingdom
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (TURANDORELA)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urinary Bladder Diseases | Male Urogenital Diseases | Female Urogenital Diseases | Urinary Bladder Neoplasm | Female Urogenital Diseases and Pregnancy Complications | Antineoplastics Toxicity | Urogenital Diseases

Netherlands
The Netherlands Cancer Institute
AstraZeneca; Daiichi Sankyo

Recruiting

Basket Study for Oligo-metastatic Breast Cancer (ANISE)

HER2-positive Breast Cancer

Netherlands
Hellenic Institute for the Study of Sepsis

Recruiting

STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care (H4COVID)

Virus Diseases | COVID-19 | Corona Virus Infection

Greece
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)

Renal Cell Carcinoma

United Kingdom, Netherlands
The Aurum Institute NPC
Johns Hopkins University

Recruiting

Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS) (DOLPHIN KIDS)

HIV | Tuberculosis

South Africa
Karolinska University Hospital
The Netherlands Cancer Institute

Recruiting

Cognition and QoL After Thyroid Surgery

Cognitive Decline | Thyroid Cancer | Thyroid Nodule | Survivorship | Symptoms, Cognitive

Sweden
The Netherlands Cancer Institute
Erasmus Medical Center

Recruiting

Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) (PUMP-IT)

Colorectal Neoplasms

Netherlands
Guangdong Provincial People's Hospital
The George Institute

Recruiting

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

CKD (Chronic Kidney Disease) Stage 5D

China
The Methodist Hospital Research Institute
Genentech, Inc.

Recruiting

Neoadjuvant Atezolizumab in Cutaneous Melanoma

Cutaneous Melanoma

United States
The Methodist Hospital Research Institute
Genentech, Inc.

Recruiting

Ocrelizumab for Psychosis by Autoimmunity (OPA)

Schizophrenia | Schizo-Affective Type of Psychosis

United States
Aarhus University Hospital
The Netherlands Cancer Institute

Recruiting

Quantitative MR Imaging in Locally Advanced Cervical Cancer (IQ-EMBRACE)

Neoplasms | Functional Magnetic Resonance Imaging | Radiotherapy

Denmark
The Cleveland Clinic
National Eye Institute (NEI)

Recruiting

DISCOVER Study: Microscope-integrated Intraoperative OCT Study (DISCOVER)

Retinal Diseases | Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Personalized Immunotherapy in Sepsis (ImmunoSep)

Sepsis

Greece, Germany, Netherlands, Romania, Switzerland
The Netherlands Cancer Institute
Anticancer Fund, Belgium

Completed

Propranolol in Angiosarcoma

Angiosarcoma

Netherlands
The Methodist Hospital Research Institute
Eisai Inc.

Enrolling by invitation

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

United States
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients (TONIC)

Breast Cancer

Netherlands
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

Hippocampus Avoidance PCI vs PCI (HA-PCI)

Small Cell Lung Cancer | Lung Cancer

Netherlands, Belgium
The University of Queensland
Telethon Kids Institute

Completed

Prevention of Bronchiectasis in Infants With Cystic Fibrosis (COMBATCF)

Bronchiectasis | Cystic Fibrosis

Australia, New Zealand
Hellenic Institute for the Study of Sepsis

Completed

Bacillus Calmette-guérin Vaccination to Prevent COVID-19 (ACTIVATEII)

Virus Diseases | COVID-19 | Chronic Obstructive Pulmonary Disease | Coronary Heart Disease | Corona Virus Infection

Greece

Clinical Trials Sponsored by The Griffin Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations